IL-17A synergizes with IFN-γ to upregulate iNOS and NO production and inhibit chlamydial growth

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Zhang, Yongci ^a   Wang, Haiping ^a   Ren, Jianyun ^a   Tang, Xiaofei ^a   Jing, Ye ^b   Xing, Donghong ^a   Zhao, Guosheng ^a   Yao, Zhi ^a   Yang, Xi ^a,c   Bai, Hong ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b Department of Clinical Laboratory   (China)

^c UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGUANIDINE; CYTOKINE; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 17; INTERLEUKIN 17ALPHA; NITRIC OXIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BACTERIAL GROWTH; CHLAMYDIA; CHLAMYDIACEAE INFECTION; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; HOST RESISTANCE; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE; MOUSE; NONHUMAN; PROTEIN EXPRESSION;

ANIMALS; CELL LINE; CHLAMYDIA INFECTIONS; CHLAMYDIA MURIDARUM; FEMALE; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-17; MICE; MICE, INBRED BALB C; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84862639907     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0039214     Document Type: Article

References (30)

1. Igietseme JU, (1996) The molecular mechanism of T-cell control of Chlamydia in mice: role of nitric oxide. Immunology 87: 1-8.
2. Byrne GI, Lehmann LK, Landry GJ, (1986) Induction of tryptophan catabolism is the mechanism for gamma-interferon-mediated inhibition of intracellular Chlamydia psittaci replication in T24 cells. Infect Immun 53: 347-351.
3. Murray HW, Szuro-Sudol A, Wellner D, Oca MJ, Granger AM, et al. (1989) Role of tryptophan degradation in respiratory burst-independent antimicrobial activity of gamma interferon-stimulated human macrophages. Infect Immun 57: 845-849.
4. Woods ML, 2nd, Mayer J, Evans TG, Hibbs JB Jr (1994) Antiparasitic effects of nitric oxide in an in vitro murine model of Chlamydia trachomatis infection and an in vivo murine model of Leishmania major infection. Immunol Ser 60: 179-195.
5. de la Maza LM, Peterson EM, Fennie CW, Czarniecki CW, (1985) The anti-chlamydial and anti-proliferative activities of recombinant murine interferon-gamma are not dependent on tryptophan concentrations. J Immunol 135: 4198-4200.
6. Rottenberg ME, Gigliotti Rothfuchs AC, Gigliotti D, Svanholm C, Bandholtz L, et al. (1999) Role of innate and adaptive immunity in the outcome of primary infection with Chlamydia pneumoniae, as analyzed in genetically modified mice. J Immunol 162: 2829-2836.
7. Rodriguez N, Lang R, Wantia N, Cirl C, Ertl T, et al. (2008) Induction of iNOS by Chlamydophila pneumoniae requires MyD88-dependent activation of JNK. J Leukoc Biol 84: 1585-1593.
8. MacMicking J, Xie QW, Nathan C, (1997) Nitric oxide and macrophage function. Annu Rev Immunol 15: 323-350.
9. Bogdan C, (2001) Nitric oxide and the immune response. Nat Immunol 2: 907-916.
10. Umemura M, Yahagi A, Hamada S, Begum MD, Watanabe H, et al. (2007) IL-17A-mediated regulation of innate and acquired immune response against pulmonary Mycobacterium bovis bacille Calmette-Guerin infection. J Immunol 178: 3786-3796.
11. Schulz SM, Kohler G, Holscher C, Iwakura Y, Alber G, (2008) IL-17AA is produced by Th17, gammadelta T cells and other CD4- lymphocytes during infection with Salmonella enterica serovar Enteritidis and has a mild effect in bacterial clearance. Int Immunol 20: 1129-1138.
12. Ye P, Garvey PB, Zhang P, Nelson S, Bagby G, et al. (2001) Interleukin-17 and lung host defense against Klebsiella pneumoniae infection. Am J Respir Cell Mol Biol 25: 335-340.
13. Chung DR, Kasper DL, Panzo RJ, Chitnis T, Grusby MJ, et al. (2003) CD4+ T cells mediate abscess formation in intra-abdominal sepsis by an IL-17A-dependent mechanism. J Immunol 170: 1958-1963.
14. Bai H, Cheng J, Gao X, Joyee AG, Fan Y, et al. (2009) IL-17A/Th17 promotes type 1 T cell immunity against pulmonary intracellular bacterial infection through modulating dendritic cell function. J Immunol 183: 5886-5895.
15. Miljkovic D, Cvetkovic I, Momcilovic M, Maksimovic-Ivanic D, Stosic-Grujicic S, et al. (2005) Interleukin-17 stimulates inducible nitric oxide synthase-dependent toxicity in mouse beta cells. Cell Mol Life Sci 62: 2658-2668.
16. Miljkovic D, Trajkovic V, (2004) Inducible nitric oxide synthase activation by interleukin-17. Cytokine Growth Factor Rev 15: 21-32.
17. Yang X, HayGlass KT, Brunham RC, (1996) Genetically determined differences in IL-10 and IFN-gamma responses correlate with clearance of Chlamydia trachomatis mouse pneumonitis infection. J Immunol 156: 4338-4344.
18. Qiu H, Yang J, Bai H, Fan Y, Wang S, et al. (2004) Less inhibition of interferon-gamma to organism growth in host cells may contribute to the high susceptibility of C3H mice to Chlamydia trachomatis lung infection. Immunology 111: 453-461.
19. Huang J, DeGraves FJ, Lenz SD, Gao D, Feng P, et al. (2002) The quantity of nitric oxide released by macrophages regulates Chlamydia-induced disease. Proc Natl Acad Sci U S A 99: 3914-3919.
20. Nussler AK, Billiar TR, (1993) Inflammation, immunoregulation, and inducible nitric oxide synthase. J Leukoc Biol 54: 171-178.
21. Ding AH, Nathan CF, Stuehr DJ, (1988) Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J Immunol 141: 2407-2412.
22. Bruch-Gerharz D, Fehsel K, Suschek C, Michel G, Ruzicka T, et al. (1996) A proinflammatory activity of interleukin 8 in human skin: expression of the inducible nitric oxide synthase in psoriatic lesions and cultured keratinocytes. J Exp Med 184(5): 2007-2012.
23. Summersgill JT, Sahney NN, Gaydos CA, Quinn TC, Ramirez JA, (1995) Inhibition of Chlamydia pneumoniae growth in HEp-2 cells pretreated with interferon and tumor necrosis factor. Infect Immun 63: 2801-2803.
24. Saura M, Zaragoza C, Bao C, McMillan A, Lowenstein CJ, (1999) Interaction of interferon regulatory factor-1 and nuclear factor κB during activation of inducible nitric oxide synthase transcription. J Mol Biol. 289: 459-471.
25. Chen B, Stout R, Campbell WF, (1996) Nitric oxide production: a mechanism of Chlamydia trachomatis inhibition in interferon-gamma-treated RAW264.7 cells. FEMS Immunol Med Microbiol 14: 109-120.
26. Schoedon G, Schneemann M, Hofer S, Guerrero L, Blau N, et al. (1993) Regulation of the L-arginine-dependent and tetrahydrobiopterin-dependent biosynthesis of nitric oxide in murine macrophages. Eur J Biochem. 213: 833-839.
27. Schneemann M, Schoedon G, Hofer S, Blau N, Guerrero L, et al. (1993) Nitric oxide synthase is not a constituent of the antimicrobial armature of human mononuclear phagocytes. J Infect Dis. 167: 1358-1363.
28. van der Veen RC, (2001) Nitric oxide and T helper cell immunity. Int Immunopharmacol 1: 1491-1500.
29. Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, et al. (2005) Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol. 6(11): 1123-1132.
30. Annunziato F, Cosmi L, Santarlasci V, Maggi L, Liotta F, et al. (2007) Phenotypic and functional features of human Th17 cells. J Exp Med. 204(8): 1849-1861.